Levosalbutamol Sulphate + Ambroxol Hydrochloride + Guaiphenesin + MentholThird Party Manufacturing in India

This combination works by providing a comprehensive, multi-targeted approach to treating wet cough and respiratory congestion.

Levosalbutamol Sulphate acts as a bronchodilator by relaxing the smooth muscles of the airways, increasing airflow. Ambroxol Hydrochloride functions as a mucolytic agent, breaking down the structure of thick mucus to make it thinner and easier to cough up. Guaiphenesin serves as an expectorant, increasing the volume and reducing the viscosity of respiratory tract secretions. Menthol provides a soothing, cooling effect on the throat, reducing irritation and the urge to cough. This combined biological effect helps the body clear congested airways and breathe easier.

Unlike single-ingredient syrups, this formulation tackles bronchospasm, thick mucus, and throat irritation simultaneously. It is highly effective and well-tolerated for patients suffering from productive coughs associated with bronchitis or asthma.

Therapeutic Uses

This combination is prescribed for the treatment of:

• Productive Cough: Effectively clears mucus-filled coughs associated with respiratory tract infections.
• Bronchial Asthma & COPD: Relieves bronchospasm and clears airways in chronic obstructive pulmonary disease and asthmatic conditions.
• Bronchitis: Alleviates chest congestion and facilitates the expectoration of thick phlegm in acute and chronic bronchitis.

Why Manufacturers Choose This Combination

This 4-in-1 formulation is a blockbuster in the Indian cough syrup market due to its comprehensive efficacy against complex respiratory symptoms. Physicians heavily prescribe this combination because it addresses the multi-faceted nature of respiratory distress—bronchoconstriction, excessive mucus, and throat irritation—in a single, convenient dose. The liquid dosage form is easily scalable and highly profitable.

This makes this specific combination one of the most sought-after formulations for third party manufacturing in India, with massive and consistent demand from PCD franchise operators and export-oriented companies, especially during seasonal allergy and flu peaks.